Evotec (NASDAQ:EVO) and Novo Nordisk (NVO) have introduced a know-how improvement partnership geared toward advancing stem cell-based therapies. The collaboration focuses on growing off-the-shelf cell remedy merchandise, addressing each medical and business wants. Underneath the phrases of the pact, Novo Nordisk will fund